FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$10.09
Tradestie Score
55
Market Cap
$407.71M
Revenue Growth
216.6%
Analyst Upside
+188.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.17
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.69
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.37
|
$540.97M | - | 50 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.06
|
$529.35M | 4.7 | 55 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$111.64
|
$522.78M | - | 51 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.33
|
$512.39M | - | 53 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$37.43
|
$505.12M | 1.9 | 58 | Compare |
|
RGNX
REGENXBIO Inc.
|
$9.96
|
$493.52M | - | 50 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$82.72
|
$492.21M | - | 50 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
More FDMT Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry